BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38897040)

  • 1. Inhibition of soluble epoxide hydrolase by natural isothiocyanates.
    Elbarbry F; Espiritu MJ; Soo K; Yee B; Taylor J
    Biochem Biophys Res Commun; 2024 Jun; 725():150261. PubMed ID: 38897040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals.
    Draper AJ; Hammock BD
    Toxicol Sci; 1999 Nov; 52(1):26-32. PubMed ID: 10568695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of soluble epoxide hydrolase inhibitors from natural products.
    Lee GH; Oh SJ; Lee SY; Lee JY; Ma JY; Kim YH; Kim SK
    Food Chem Toxicol; 2014 Feb; 64():225-30. PubMed ID: 24309146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
    DuTeaux SB; Newman JW; Morisseau C; Fairbairn EA; Jelks K; Hammock BD; Miller MG
    Toxicol Sci; 2004 Apr; 78(2):187-95. PubMed ID: 14737000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes.
    Bogaards JJ; Venekamp JC; van Bladeren PJ
    Chem Biol Interact; 1996 Dec; 102(3):169-82. PubMed ID: 9021169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation.
    Peng Y; Wu H; Zhang X; Zhang F; Qi H; Zhong Y; Wang Y; Sang H; Wang G; Sun J
    Xenobiotica; 2015; 45(11):961-77. PubMed ID: 26007223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes.
    Conaway CC; Krzeminski J; Amin S; Chung FL
    Chem Res Toxicol; 2001 Sep; 14(9):1170-6. PubMed ID: 11559030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics.
    Zhao WY; Yan JJ; Zhang M; Wang C; Feng L; Lv X; Huo XK; Sun CP; Chen LX; Ma XC
    Chem Biol Interact; 2021 Aug; 345():109571. PubMed ID: 34217688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
    Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
    Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides.
    Dang J; Du S; Wang L
    Foods; 2022 Nov; 11(22):. PubMed ID: 36429288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase.
    Xu M; Hao H; Jiang L; Long F; Wei Y; Ji H; Sun B; Peng Y; Wang G; Ju W; Li P
    Phytomedicine; 2015 Apr; 22(4):444-51. PubMed ID: 25925966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase.
    Zhao WY; Zhang XY; Zhou MR; Tian XG; Lv X; Zhang HL; Deng S; Zhang BJ; Sun CP; Ma XC
    Int J Biol Macromol; 2021 Jul; 183():811-817. PubMed ID: 33957203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
    Wang Y; Wu S; Chen Z; Zhang H; Zhao W
    J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.
    Morisseau C; Kodani SD; Kamita SG; Yang J; Lee KSS; Hammock BD
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
    Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
    Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
    Ahmed ZSO; Li X; Li F; Cheaito HA; Patel K; Mosallam EM; Elbargeesy GAEH; Dou QP
    J Cell Biochem; 2018 Nov; 119(11):9006-9016. PubMed ID: 30015387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    Taavitsainen P; Juvonen R; Pelkonen O
    Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
    Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.